For over 23 years Matthew Zicaro has been working in the biotechnology and pharmaceutical industry. Recently working with the some of the fastest growing biotechnology companies in the world, Matthew has extensive experience in the development and the buildout of millions of square feet of life science facilities. Matthew had direct involvement in conceptual design, site selection, site master planning, detail design, construction, facility startup, commissioning, qualification, validation and ensuring regulatory audit readiness.

The creation of Galaxy Life Sciences combined Matthew’s experience with Galaxy Development, which under the leadership of Mike O’Brien has developed millions of square feet of the highest quality retail, office, and healthcare properties in Massachusetts, Connecticut, New Hampshire, and New York. This portfolio, 25 years in the making, is mostly ground-up construction projects which created thousands of jobs. Galaxy is now an established real estate development machine that is geared up to move forward at a very swift pace. The team has extensive experience in all phases of permitting, land development, real estate negotiation, site selection, environmental cleanup, infrastructure improvements, site planning, financing, leasing, permitting, design and construction of real estate.

Bringing ATMPs to Market With Flexible and Sustainable Manufacturing

Biopharmaceutical companies are moving swiftly to develop Advanced Therapy Medicinal Products (ATMP), which are medicines based on genes, tissues or cells. These can offer groundbreaking new opportunities for the treatment of disease and injury. But there are challenges involved in bringing these innovative products through clinical phase to commercial production phase.

Firms want to be able to develop multiple product types to allow for the adaptability to meet emerging demand and an evolving product pipeline. They also want facilities that embrace innovations and technologies in the products and processes that are yet to come. There’s a need for flexible, resilient and sustainable manufacturing.

Developing Dynamic, Future-Proof, Multi-Modal Facilities

Galaxy Life Sciences delivers flexible, future-proof facilities. Our projects accommodate the development and manufacturing of multiple types of processes, including biologics, cell therapies and gene therapies.

We provide the ability to scale appropriately to achieve faster speed-to-market, lower costs and ultimate manufacturing flexibility.